MDMA is named as an intervention in 3 current clinical trials in our Switzerland and Canada registers. 3 are recruiting patients now. The most common phase is Phase 1. The sponsor with the most trials is University Hospital, Basel, Switzerland (2). The most-studied condition is Healhty.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
NCT07301632 · ClinicalTrials.gov ↗ · Chronic Neuropathic Pain
|
Phase 2 | Recruiting | Unity Health Toronto | Canada |
|
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
NCT07494214 · ClinicalTrials.gov ↗ · Healhty
|
Phase 1 | Recruiting | University Hospital, Basel, Switzerland | Switzerland |
|
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
NCT06789705 · ClinicalTrials.gov ↗ · Central Diabetes Insipidus
|
Not applicable | Recruiting | University Hospital, Basel, Switzerland | Switzerland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University Hospital, Basel, Switzerland | 2 |
| Unity Health Toronto | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Switzerland | 2 | 2 |
| Clinical trials in Canada | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our Switzerland and Canada registers name MDMA (also registered as 3,4-Methylenedioxymethamphetamine) as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 3 trials are recruiting: 2 with sites in Switzerland and 1 with sites in Canada. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
University Hospital, Basel, Switzerland (2) and Unity Health Toronto (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how MDMA works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how MDMA works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists MDMA (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.